Janney Montgomery Scott LLC Eli Lilly & CO Transaction History

Janney Montgomery Scott LLC

$35.8 Billion
Q3 2024

A detailed history of Janney Montgomery Scott LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 282,040 shares of LLY stock, worth $212 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

282,040

Previous 277,200 1.75%

Holding current value

$212 Million

Previous $251 Million 0.44%

% of portfolio

0.7%

Previous 0.77%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$772.14 - $960.02 $3.74 Million - $4.65 Million	4,840 Added 1.75%	282,040 $250 Million
Q2 2024 Jul 25, 2024	SELL	$724.87 - $909.04 $27.2 Million - $34.1 Million	-37,516 Reduced 11.92%	277,200 $251 Million
Q1 2024 May 01, 2024	BUY	$592.2 - $792.28 $29.8 Million - $39.9 Million	50,367 Added 19.05%	314,716 $245 Million
Q4 2023 Feb 07, 2024	SELL	$525.19 - $619.13 $5.42 Million - $6.39 Million	-10,328 Reduced 3.76%	264,349 $154 Million
Q3 2023 Nov 08, 2023	BUY	$434.7 - $599.3 $7.85 Million - $10.8 Million	18,048 Added 7.03%	274,677 $148 Million
Q2 2023 Jul 26, 2023	BUY	$350.74 - $468.98 $4.17 Million - $5.58 Million	11,896 Added 4.86%	256,629 $120 Million
Q1 2023 Apr 28, 2023	BUY	$310.63 - $364.82 $3.37 Million - $3.96 Million	10,853 Added 4.64%	244,733 $84 Million
Q4 2022 Feb 01, 2023	BUY	$321.55 - $374.67 $4.12 Million - $4.8 Million	12,816 Added 5.8%	233,880 $85.6 Million
Q3 2022 Oct 25, 2022	SELL	$296.48 - $337.87 $813,837 - $927,453	-2,745 Reduced 1.23%	221,064 $71.5 Million
Q2 2022 Aug 03, 2022	SELL	$278.73 - $327.27 $4.21 Million - $4.94 Million	-15,087 Reduced 6.32%	223,809 $71.5 Million
Q1 2022 May 04, 2022	BUY	$234.69 - $291.66 $609,255 - $757,149	2,596 Added 1.1%	238,896 $68.4 Million
Q4 2021 Jan 27, 2022	SELL	$224.85 - $279.04 $1.19 Million - $1.48 Million	-5,297 Reduced 2.19%	236,300 $65.3 Million
Q3 2021 Oct 29, 2021	BUY	$221.6 - $272.71 $567,960 - $698,955	2,563 Added 1.07%	241,597 $55.8 Million
Q2 2021 Jul 26, 2021	SELL	$180.55 - $233.54 $2.08 Million - $2.69 Million	-11,536 Reduced 4.6%	239,034 $54.9 Million
Q1 2021 Apr 27, 2021	SELL	$164.32 - $212.72 $852,327 - $1.1 Million	-5,187 Reduced 2.03%	250,570 $46.8 Million
Q4 2020 Jan 25, 2021	BUY	$130.46 - $172.63 $1.38 Million - $1.83 Million	10,579 Added 4.31%	255,757 $43.2 Million
Q3 2020 Nov 06, 2020	SELL	$146.22 - $169.13 $440,414 - $509,419	-3,012 Reduced 1.21%	245,178 $36.3 Million
Q2 2020 Jul 23, 2020	BUY	$136.42 - $164.18 $2.9 Million - $3.49 Million	21,238 Added 9.36%	248,190 $40.7 Million
Q1 2020 Apr 30, 2020	BUY	$119.05 - $147.35 $2.3 Million - $2.85 Million	19,316 Added 9.3%	226,952 $31.5 Million
Q4 2019 Jan 21, 2020	SELL	$106.92 - $132.43 $2.8 Million - $3.46 Million	-26,145 Reduced 11.18%	207,636 $27.3 Million
Q3 2019 Oct 29, 2019	BUY	$106.79 - $116.16 $819,399 - $891,295	7,673 Added 3.39%	233,781 $26.1 Million
Q2 2019 Jul 29, 2019	BUY	$110.79 - $129.32 $348,212 - $406,452	3,143 Added 1.41%	226,108 $25.1 Million
Q1 2019 Apr 30, 2019	BUY	$111.31 - $131.02 $968,953 - $1.14 Million	8,705 Added 4.06%	222,965 $28.9 Million
Q4 2018 Feb 01, 2019	BUY	$105.9 - $118.64 $474,432 - $531,507	4,480 Added 2.14%	214,260 $24.8 Million
Q3 2018 Nov 05, 2018	SELL	$85.86 - $107.31 $635,278 - $793,986	-7,399 Reduced 3.41%	209,780 $22.5 Million
Q2 2018 Jul 24, 2018	SELL	$75.7 - $86.88 $160,938 - $184,706	-2,126 Reduced 0.97%	217,179 $18.5 Million
Q1 2018 Apr 19, 2018	SELL	$74.21 - $87.6 $319,696 - $377,380	-4,308 Reduced 1.93%	219,305 $17 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $1.29 Million - $1.39 Million	15,791 Added 7.6%	223,613 $18.9 Million
Q3 2017 Nov 15, 2017	BUY	$77.07 - $85.54 $16 Million - $17.8 Million	207,822	207,822 $17.8 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Account

Janney Montgomery Scott LLC Eli Lilly & CO Transaction History